Laura Williams
Vermogen: 1 M $ op 31-08-2026
Vermogen: 1 M $ op 31-08-2026
Laura A. Williams is Chief Patient Officer at Ardelyx, Inc. since 2025.
Formerly, Dr. Williams was Independent Director at Imara, Inc. from 2021 to 2023, Senior Vice President-Clinical Development at AMAG Pharmaceuticals, Inc. from 2017 to 2020, and Vice President-Clinical Development at Myovant Sciences, Inc. from 2016 to 2017.
Education includes graduate studies at the University of Washington, undergraduate studies at Mississippi State University, and a doctorate from the University of Iowa.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARDELYX, INC. 0,15% | 21-08-2026 | 367.456 ( 0,15% ) | 1 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARDELYX, INC. | Corporate Officer/Principal | 01-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IMARA | Directeur/Bestuurslid | 01-02-2023 |
| AMAG PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Hoofd Techniek/Wetenschap/O&O | 01-08-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mississippi State University
Mississippi State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for maternal & women health, anemia management and cancer supportive care | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Imara, Inc.
Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau